Health
Novel treatment avenue for resistant cancers: Removing SORLA protein from drug-resistant HER2-positive cancer cell lines – Medical Xpress
SORLA is a protein trafficking receptor that has been mainly studied in neurons, but it also plays a role in cancer cells. Professor Johanna Ivaska’s research group…
SORLA is a protein trafficking receptor that has been mainly studied in neurons, but it also plays a role in cancer cells. Professor Johanna Ivaska’s research group at Turku Bioscience observed that SORLA functionally contributes to the most reported therapy-resistant mechanism by which the cell-surface receptor HER3 counteracts HER2 targeting therapy in HER2-positive cancers. Removing SORLA from cancer cells sensitized anti-HER2 resistant breast cancer brain metastasis to targeted therapy.
HER2…
-
Noosa News20 hours agoGirl on scooter dies in Laidley, motorbike rider killed in Gatton
-
Noosa News15 hours agoLaidley e-scooter death: Tragic new details after Summah Richards killed in freak accident
-
Noosa News21 hours agoGirl killed in horror e-scooter crash in Laidley, Queensland
-
General20 hours agoBrisbane coach Michael Maguire backs Reece Walsh despite error handing Broncos defeat